Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study

NCT01235377 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

FED

Sponsor class

Conditions

Hypertension

Interventions

OTHER: Favor one of two thiazides for new prescriptions & attempt target dose

Sponsor

VA Pharmacy Benefits Management Strategic Healthcare Group